References

Davies, T.A., G.A. Pankuch, B.E. Dewasse, M.R. Jacobs and P.C. Appelbaum, 1999. In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae. Antimicrob. Agents Chemother., 43: 1177-1182.
PubMed  |  

Escudero, J.A., A.S. Millan, A. Catalan, A.G. de la Campa and E. Rivero et al., 2007. First characterization of fluoroquinolone resistance in Streptococcus suis. Antimicrob. Agents Chemother, 51: 777-782.
PubMed  |  

Hopkins, K.L., L. Wootton, M.R. Day and E.J. Threlfall, 2007. Plasmid mediated quinolone resistance determinant qnrS1 found in Salmonella enteric strains isolated in the UK. J. Antimicrob. Chemother., 59: 1071-1075.
PubMed  |  Direct Link  |  

Kongwang, H.E. and L. Chengping, 2000. Pathopoiesis and virulence genes of Streptococcus suis serotypes 2. Vet. Sci. China, 30: 17-18.

Najati, N. and L. Saboktakin, 2010. Prevalence and underlying etiologies of neonatal hypoglycemia. Pak. J. Biol. Sci., 13: 753-756.
CrossRef  |  

National Committee for Clinical Laboartory Standards, 2000. Perfomrance Standards for Antimicrobial Disk and Dilution Susceptibility Test for Bacteria Isolated from Animals: Approved Standard. NCCLS document M31-A2, Wayne,USA..

Seyed, Z.B., S.S. Tabrizi and G.R. Abdollahpour, 2011. Stomatocytosis in the ruminent: A first report. Asian J. Anim. Vet. Adv., 63: 1089-1093.
CrossRef  |  Direct Link  |  

Varon, E., C. Janoir, M.D. Kitzis and L. Gutmann, 1999. ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae. Antimicrob. Agents Chemother., 43: 302-306.
PubMed  |  

Wang, D.D., T.Y. Sun and Y.J. Hu, 2007. Contributions of efflux pumps to high level resistance of Pseudomonas aeruginosa to ciprofloxacin. Chin. Med. J., 120: 68-70.
PubMed  |  

Yuan, Q., Q. Wang and X.Y. Li, 2009. Relationship between ciprofloxa cinres is tance and gyrA, parC gene mutation in Streptococcus suis. Chin. J. Prev. Vet. Med., 31: 201-203.